Previous Close | 1.0700 |
Open | 0.0000 |
Bid | 0.9600 x N/A |
Ask | 1.0000 x N/A |
Day's Range | 0.0000 - 0.0000 |
52 Week Range | |
Volume | |
Avg. Volume | 138,014 |
Market Cap | 67.204M |
Beta (5Y Monthly) | 2.25 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -4.9800 |
Earnings Date | Mar 09, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 15.17 |
Subscribe to Yahoo Finance Plus to view Fair Value for AYR-A.CN
Ayr Wellness Inc. (AYRWF) delivered earnings and revenue surprises of 48% and 5.99%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
MIAMI, March 09, 2023 (GLOBE NEWSWIRE) -- Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“Ayr” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator (“MSO”), is reporting financial results for the fourth quarter and full year ended December 31, 2022. Unless otherwise noted, all results are presented in U.S. dollars. David Goubert, President & CEO of Ayr, said, “I’d like to thank our team for pulling together to deliver a strong fourth quarter, growing our adjusted
Jonathan Sandelman becomes Executive Chairman of the Board; Management to Host Q4 and FY 2022 Conference Call on March 9, 2023, at 8:30 a.m. ETMIAMI, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“Ayr” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator (“MSO”), today announced that Jonathan Sandelman has transitioned to Executive Chair, where he will continue to serve the Company’s Board of Directors, and David Goubert, current